Broxyquinoline
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101640This classification denotes an anti-infective agent with the molecular formula C9H5Br2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK4C618C8T, chemically known as 5,7-dibromooxine but generally known as broxyquinoline, which bears US NIH Compound Identifier 2453. European Medicines Agency schedules Broxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05940MIG. The term BROXYQUINOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules broxyquinoline in its Anatomical Therapeutic Chemical (ATC) Classification. BROXYQUINOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule broxyquinoline under HS 29334990 and SITC 51575. As of Q4 2014, BROXYQUINOLINE remains the US FDA Preferred Term for this commodity. Broxyquinoline bears US NLM identifiers UMLS ID C0054157 and NCI Concept Code C73253. SMILES: BRC1C2C(NCCC2)C(O)C(BR)C1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.